EMEA-003302-PIP01-22
Submitted by Anonymous (not verified) on 7 June 2024 - 11:07
EMEA-003302-PIP01-22
EMEA-003279-PIP01-22
Submitted by Anonymous (not verified) on 7 June 2024 - 11:05
EMEA-003279-PIP01-22
EMEA-003251-PIP01-22
Submitted by Anonymous (not verified) on 7 June 2024 - 11:02
EMEA-003251-PIP01-22
EMEA-003208-PIP02-22
Submitted by Anonymous (not verified) on 7 June 2024 - 10:55
EMEA-003208-PIP02-22
EMEA-001231-PIP02-13-M10
Submitted by Anonymous (not verified) on 7 June 2024 - 10:28
EMEA-001231-PIP02-13-M10
Opinion/decision on a Paediatric investigation plan (PIP): Tremfya, Guselkumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0190/2023
Submitted by Anonymous (not verified) on 7 June 2024 - 10:26
Opinion/decision on a Paediatric investigation plan (PIP): Tremfya, Guselkumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0190/2023
Opinion/decision on a Paediatric investigation plan (PIP): Vaxchora, Cholera vaccine, live attenuated, oral (strain CVD 103-HgR), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number: P/0
Submitted by Anonymous (not verified) on 7 June 2024 - 10:21
Opinion/decision on a Paediatric investigation plan (PIP): Vaxchora, Cholera vaccine, live attenuated, oral (strain CVD 103-HgR), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number: P/0189/2023
EMEA-001238-PIP03-21-M01
Submitted by Anonymous (not verified) on 7 June 2024 - 10:15
EMEA-001238-PIP03-21-M01
Human medicines European public assessment report (EPAR): Parsabiv, etelcalcetide, Date of authorisation: 11/11/2016, Revision: 10, Status: Authorised
Submitted by Anonymous (not verified) on 7 June 2024 - 10:03
Human medicines European public assessment report (EPAR): Parsabiv, etelcalcetide, Date of authorisation: 11/11/2016, Revision: 10, Status: Authorised
Methodology Working Party Interested Parties Meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 June 2024, 09:00 (CEST) to 7 June 2024, 13:00 (CEST)
Submitted by Anonymous (not verified) on 7 June 2024 - 9:40
Methodology Working Party Interested Parties Meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 June 2024, 09:00 (CEST) to 7 June 2024, 13:00 (CEST)